Developing sensitive techniques to analyze proteins in small samples
Robust ultra-high sensitivity proteomic technologies for limited samples
['FUNDING_OTHER'] · NORTHEASTERN UNIVERSITY · NIH-10874484
This study is working on new ways to look at proteins in tiny samples from biopsies or blood tests, which could help us understand diseases like cancer better and lead to more personalized treatments just for you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHEASTERN UNIVERSITY (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10874484 on ClinicalTrials.gov |
What this research studies
This research focuses on creating advanced proteomic technologies that can analyze proteins from very limited biological samples, such as those obtained from biopsies or blood tests. By improving the sensitivity of these techniques, the research aims to better understand protein interactions and modifications that can lead to diseases like cancer. The approach involves using innovative methods to study small populations of cells, which are often overlooked due to traditional techniques' limitations. This could enhance diagnostics and the development of targeted therapies in personalized medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cancer or other conditions where limited biological samples are available for analysis.
Not a fit: Patients with abundant biological samples or those not affected by diseases related to protein interactions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and personalized treatment options for patients with cancer and other diseases.
How similar studies have performed: Other research has shown promise in developing sensitive proteomic techniques, indicating potential for success in this novel approach.
Where this research is happening
BOSTON, UNITED STATES
- NORTHEASTERN UNIVERSITY — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: IVANOV, ALEXANDER R. — NORTHEASTERN UNIVERSITY
- Study coordinator: IVANOV, ALEXANDER R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer cell line, Cancers